Several companies under the Lianhuan Pharmaceutical Industry have signed a strategic cooperation agreement.

On September 10th, Chengdu Asia-Pacific Biopharmaceutical Co., Ltd. signed a deep strategic cooperation agreement with Yangzhou Lianhuan Investment Co., Ltd. and Nanjing Lianzhi Pharmaceutical Technology Co., Ltd. As a subsidiary of Lianhuan Pharmaceutical Industry, the three parties of Asia-Pacific Pharmaceuticals, Lianhuan Investment, and Nanjing Lianzhi will jointly establish a project team to fully promote the early listing and early transformation of research and development varieties; at the same time, through deep integration of the upstream and downstream of the industrial chain, further enhance Lianhuan Pharmaceutical Industry's core competitiveness in the field of cardiovascular treatment.